Global Anti-Infective Vaccines Market Report 2017: Analysis By Disease Type (Bacterial, Viral), Region & Country 2016-2021 - Rising Incidences of Typhoid, TB, Hepatitis and Influenza

Dublin, April 04, 2017 -- Research and Markets has announced the addition of the "Global Anti-Infective Vaccines Market - Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021)" report to their offering.

Global Anti-infective vaccine Market is forecasted to grow at a CAGR of 5.88% during 2016-2021F, on account of rising incidences of typhoid, TB, hepatitis and Influenza among the growing population across the globe. North America region remains the major market followed by Europe in the actual period, while APAC and ROW region will witness strong growth in the forecast period.

Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand for anti-infective vaccines. Rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective vaccines market. Further, rising concerns over bioterrorism due to biological weapons along with increasing focus on the immunization programmes for prevention of diseases have been contributing in the growth of Anti Infective Vaccines.

Among the types of bacterial diseases, market is expected to be driven by typhoid and TB, mainly due to high number of cases in developing regions. However, antiviral vaccines will continue to generate major revenue due to increases R&D expenses along with rising number cases for various diseases like Influenza and ZIKA virus in developed regions.While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population along with escalating expenditure on immunization programmes by various NGO's.

Scope of the Report

The report provides Segmentation by Vaccine Type:

- Anti-Bacterial
- Anti-Viral

Segmentation by Sub - Type:

- Anti-Bacterial - Diseases Type, TB Typhoid and Other's
- Anti-Viral Type - Diseases Type, Hepatitis, Influenza and Other's

Coverage by Region:

- North America
- Europe
- Asia Pacific
- ROW

Coverage by Country:

- USA
- Canada
- UK
- France
- India
- China

Companies Mentioned

- Astrazeneca
- CSL Limited
- Emergent Biosolutions
- GlaxoSmithKline
- Merck & Co. Inc.
- Pfizer
- Protein Sciences Corporation
- Sanofi Pasteur Inc.
- Serum Institute Of India Pvt. Ltd.
- Teva Pharmaceutical Industries Ltd.

For more information about this report visit http://www.researchandmarkets.com/research/34nrrt/global

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Infectious Diseases Drugs, Vaccines